Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda licences psychiatry programmes to Neurocrine Biosciences

pharmaceutical-technologyJune 18, 2020

Tag: Takeda , Neurocrine Biosciences , schizophrenia

PharmaSources Customer Service